Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-04-15 | Reverse | 1:35 |
Scilex Holding Company, based in Palo Alto, develops non-opioid pain management products like ZTlido for neuropathic pain and is advancing several clinical-stage treatments for conditions such as radicular pain, low back pain, and fibromyalgia.

GLOPERBA® is the first liquid oral colchicine formulation, launched in the U.S. in June 2024, offering precise dosing for gout flare prevention, especially benefiting patients with specific health needs or tablet-related side effects.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
IRD | $5.80 | COMPARE |
AGEN | $7.06 | COMPARE |
ALEC | $2.06 | COMPARE |
ABOS | $2.83 | COMPARE |
LUCD | $0.80 | COMPARE |
SEER | $1.91 | COMPARE |
INO | $1.18 | COMPARE |
CTOR | $0.87 | COMPARE |